Drug-labels.com

Apo-Abacavir: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
300 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Apo-Abacavir

Serious Warnings and Precautions

Hypersensitivity Reaction

Serious and sometimes fatal hypersensitivity reactions (serious allergic reactions) have happened in people taking abacavir and other medicines containing abacavir. You should be screened for the HLA-B*5701 gene variation prior to starting or re-starting treatment with APO-ABACAVIR, unless you have been screened previously and this is documented. Patients who have the HLA-B*5701 gene variation have a high risk of developing a hypersensitivity reaction to abacavir, which is the medicinal ingredient in APO-ABACAVIR. This hypersensitivity reaction can be life threatening if you continue to take APO-ABACAVIR. Do not take APO-ABACAVIR if you have the HLA-B*5701 gene variation or have had a reaction in the past to APO-ABACAVIR or any other medicine containing abacavir (such as TRIZIVIR (no longer marketed in Canada), KIVEXA or TRIUMEQ).

If you stop APO-ABACAVIR because of a hypersensitivity reaction, never take APO-ABACAVIR or any other medicine containing abacavir again, regardless of whether you have the HLA-B*5701 gene variation or not. If you restart APO-ABACAVIR or any other medicine containing abacavir, within hours you may experience a life threatening lowering of your blood pressure or death.

If you stop APO-ABACAVIR for any other reason, even for a few days, and you are not allergic to APO-ABACAVIR, talk with your healthcare professional before taking it again. Taking APO-ABACAVIR again may cause a serious allergic or life-threatening reaction, even if you never had an allergic reaction to it before.

Important Information on Hypersensitivity Reactions

If you get two or more of the following groups of symptoms while taking APO-ABACAVIR contact your healthcare professional immediately to find out if you should stop taking APO-ABACAVIR:

SYMPTOM(S)
Group 1Fever
Group 2Rash
Group 3Nausea, vomiting, diarrhea, or abdominal (stomach area) pain
Group 4Generally ill feeling, extreme tiredness or achiness
Group 5Shortness of breath, cough or sore throat

A list of these symptoms is on the Warning Card provided by your healthcare professional. You should carry this Warning Card with you at all times. If you notice these symptoms while taking APO-ABACAVIR, call your healthcare professional immediately. Your healthcare professional may advise you to stop taking APO-ABACAVIR.

If your healthcare professional tells you that you can take APO-ABACAVIR, again, start taking it when you are around medical help or people who can call a healthcare professional if you need one.

Occasionally, reactions have developed in people who start taking abacavir again, and had only one symptom on the Warning Card before they stopped taking it.

If you are hypersensitive (allergic) to APO-ABACAVIR, return all your unused APO-ABACAVIR tablets for safe disposal. Ask your healthcare professional for advice.

What is APO-ABACAVIR used for?

APO-ABACAVIR is a medicine used with other antiretrovirals to treat Human Immunodeficiency Virus (HIV) infection.

How does APO-ABACAVIR work?

APO-ABACAVIR contains the medicinal ingredient abacavir sulfate. This belongs to a group of antiretroviral medicines called nucleoside analogue reverse transcriptase inhibitors (NRTIs), which are used to treat HIV infection.

HIV is a retrovirus (a type of virus). Infection with HIV damages the immune system and can lead to Acquired Immune Deficiency Syndrome (AIDS) and other related illnesses.

APO-ABACAVIR does not cure HIV infection; it reduces the amount of virus in your body, and keeps it at a low level. It also increases the CD4 cell count in your blood. CD4 cells are a type of white blood cells that are important in helping your body to fight infection.

What are the ingredients in APO-ABACAVIR?

Medicinal ingredients: Abacavir (as abacavir sulfate).

Non-medicinal ingredients: Colloidal silicon dioxide, croscarmellose sodium, hydroxy propyl methyl cellulose, iron oxide yellow, magnesium stearate, microcrystalline cellulose, polyethylene glycol and titanium dioxide.

APO-ABACAVIR comes in the following dosage forms:

300 mg tablets

Do not use APO-ABACAVIR if you:

  • previously had an allergic reaction (hypersensitivity) to the medicinal ingredient abacavir, which is also included in medicines called KIVEXA, TRIUMEQ and TRIZIVIR (no longer marketed in Canada), or to any of the other ingredients found in APO-ABACAVIR.
  • have the HLA-B* 5701 gene variation.
  • have moderate or severe liver disease.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take APO-ABACAVIR. Talk about any health conditions or problems you may have, including if you:

  • have liver problems
  • have been tested and know whether or not you have a gene variation called HLA-B*5701
  • are already taking a medicine that contains abacavir, including KIVEXA or TRIUMEQ.
  • or the person your are caring for is less than 3 months of age or 65 years of age or older

Other warnings you should know about:

APO-ABACAVIR can cause serious side effects, including:

  • Lactic Acidosis and Severe Liver Problems: The class of medicines to which APO-ABACAVIR belongs (NRTIs) can cause a condition called lactic acidosis (excess of lactic acid in your blood), together with an enlarged liver. Symptoms of lactic acidosis include feeling of weakness, loss of appetite, sudden unexplained weight loss, upset stomach and difficulty breathing or rapid breathing. This rare, but serious side effect occurs more often in women. If you have liver problems you may also be more at risk of getting this condition.
  • Heart Attack: Some HIV medicines including abacavir may increase your risk of heart attack. If you have heart problems, smoke or suffer from diseases that increase your risk of heart disease such as high blood pressure and diabetes, tell your healthcare professional.
  • Risk of Infections: You may continue to develop other infections and other illnesses associated with HIV while you are taking APO-ABACAVIR. You should therefore keep in regular contact with your healthcare professional.
  • Immune Reconstitution Inflammatory Syndrome: Changes to your immune system can happen when you start taking HIV-1 medicines. Your immune system may get stronger

Autoimmune disorders happen when the immune system attacks healthy body tissue. This may happen after you start taking medicines for HIV infection. Examples of this include: Grave's disease (which affects the thyroid gland), Guillain-Barré syndrome (which affects the nervous system), polymyositis (which affects the muscles), or autoimmune hepatitis (which affects the liver). Autoimmune disorders may occur many months after the start of treatment.

See the Serious side effects and what to do about them table, below, for more information on these and other serious side effects.

Blood Tests: Your blood sugar levels (glucose) or level of fats (lipids) in your blood may increase with HIV treatment. Your healthcare professional will decide when to do blood tests, to check for these and other side effects, and will interpret the results.

Pregnancy and Newborns: If you are pregnant, or planning to become pregnant, talk to your healthcare professional before taking APO-ABACAVIR. It is not known if APO-ABACAVIR is safe to use during pregnancy. Your healthcare professional will decide whether you should continue to take APO-ABACAVIR if you are pregnant. If you are pregnant and taking APO-ABACAVIR to prevent passing HIV to your unborn baby continue to follow your healthcare professionals recommendations. If you have questions about the risks to your baby talk to your healthcare professional. If you take APO-ABACAVIR while you are pregnant, talk to your healthcare professional about how you can be included in the Antiretroviral Pregnancy Registry.

Babies born to mothers who have taken Nucleoside Reverse Transcriptase Inhibitors (NRTIs) like APO-ABACAVIR during pregnancy or labour have had increased levels of lactate in their blood. The increases are usually temporary. There have also been very rare reports of problems that affect the babies nervous system such as delayed development and seizures. The longterm effects of APO-ABACAVIR are not known.

Breastfeeding: Do not breastfeed while taking APO-ABACAVIR. There is a risk of passing HIV-1 to your baby if you breastfeed. Abacavir can also be passed through breast milk and could harm your baby. If you are breastfeeding or planning to breastfeed, talk with your healthcare professional about the best way to feed your baby.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with APO-ABACAVIR:

  • Methadone, to treat pain and drug addiction
  • Retinoids, to treat skin conditions
  • Riociguat, to treat high blood pressure
  • Alcohol

Talk to your healthcare professional for further advice if you are taking any of these medicines. For some of these medicines, your healthcare professional may need to adjust the dose of one of your medicines in order for it to work properly.

How to take APO-ABACAVIR:

  • Take APO-ABACAVIR exactly as directed by your healthcare professional. If you are unsure about how to take it, ask your healthcare professional.
  • You can take APO-ABACAVIR with or without food.

  • APO-ABACAVIR is always prescribed with other antiretroviral agents.
  • If you have liver problems your healthcare professional may have to adjust your dose.
  • APO-ABACAVIR tablets can be given to children and adults able to swallow tablets.

Usual dose:

Adults, Adolescents and Children (weighing at least 25 kg): 600 mg daily.

  • Tablets: 1 tablet (300 mg) twice daily or 2 tablets (600 mg) once daily

Adolescents and children (≥ 3 months of age and weighing less than 25 kg): The dose of APO-ABACAVIR tablets will be decided by your healthcare professional based on your child’s weight.

Overdose:

If you think you, or a person you are caring for, have taken too much APO-ABACAVIR, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

It is important to take this medicine as prescribed to ensure you get maximum benefit. If you forget to take a dose, take it as soon as you remember, and then continue as before. Do not take a double dose to make up for forgotten individual doses.

If you stopped taking APO-ABACAVIR:

If you stop taking APO-ABACAVIR because of side effects or illness, you must contact your healthcare professional before restarting to make sure that symptoms of a hypersensitivity reaction have not been missed. In some cases your healthcare professional will ask you to restart APO-ABACAVIR under direct medical supervision or in a place where you will be able to get ready access to medical care if needed.

What are possible side effects from using APO-ABACAVIR?

These are not all the possible side effects you may feel when taking APO-ABACAVIR. If you experience any side effects not listed here, contact your healthcare professional.

Like all medicines, APO-ABACAVIR can have side effects. When treating HIV infection, it is not always possible to tell whether some of the side effects that occur are caused by APO-ABACAVIR, by other medicines you are taking at the same time or by the HIV infection. For this reason it is very important that you inform your healthcare professional about any changes in your health.

Side effects may include:

  • nausea (feeling sick), vomiting
  • diarrhea
  • loss of appetite
  • lack of energy, fatigue
  • fever
  • headache
  • rash
Serious side effects and what to do about them
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
COMMON

Hypersensitivity Reaction/Serious Allergic Reaction, which can present as skin rash and/or symptoms from at least 2 of the following groups:

  • fever
  • shortness of breath, sore throat or cough
  • nausea or vomiting, diarrhea, or stomach pain
  • severe tiredness or achiness, or generally feeling ill.
√
RARE
Lactic Acidosis (high level of acid in the blood) and Liver Problems: weight loss, fatigue, malaise, abdominal pain, shortness of breath, swollen and enlarged liver with symptoms of liver√
Serious side effects and what to do about them
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
problems such as nausea, vomiting, abdominal pain, weakness and diarrhea
Pancreatitis (inflammation of the pancreas): abdominal pain that lasts and gets worse when you lie down, nausea, vomiting√
VERY RARE
Serious Skin Reactions [erythema multiforme, Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)]: severe rash, itching, fever, swollen lymph nodes, flu-like feeling, blisters and peeling of skin that may start in and around the mouth, nose, eyes and genitals and spread to other areas of the body√
FREQUENCY NOT KNOWN
Immune Reconstitution Inflammatory Syndrome and Autoimmune Disorders: fever, redness, rash or swelling, fatigue, joint or muscle pain, numbness or weakness beginning in the hands and feet and moving up towards the trunk of the body, palpitations, chest pain or rapid heart rate, yellowing of the eyes and skin√
Heart Attack: chest pain or discomfort, pain in the jaw, neck or back or pain radiating down the left arm, shortness of breath, nausea, dizziness√

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store APO-ABACAVIR tablets between 15°C and 30°C.

Keep out of reach and sight of children.

Do not take your medicine after the expiry date shown on the bottle and/or the carton.

If you want more information about APO-ABACAVIR:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website (http://www.apotex.ca/products), or by calling 1-800-667-4708.

Last Revised:

INFORMATION FOR PRESCRIBERS:

A copy of the warning card included with the APO-ABACAVIR carton is shown below.

WARNING CARD

APO-ABACAVIR (Abacavir Tablets USP)

Patients taking APO-ABACAVIR (Abacavir Tablets USP) may develop a hypersensitivity reaction (a serious allergic reaction) which can be life-threatening if you continue to take APO-ABACAVIR. If you notice two or more of the following sets of symptoms while taking APO-ABACAVIR, contact your healthcare professional immediately to find out if you should stop taking APO-ABACAVIR.

SYMPTOM(S)
Group 1Fever
Group 2Rash
Group 3Nausea, vomiting, diarrhea, or abdominal (stomach area) pain
Group 4Generally ill feeling, extreme tiredness or achiness
Group 5Shortness of breath, cough or sore throat

If you have already had this reaction to APO-ABACAVIR, never take any medicine containing abacavir, such as KIVEXA® (abacavir /lamivudine), TRIUMEQ® (dolutegravir/ abacavir/lamivudine) or ZIAGEN (abacavir) again. If you take any medicine containing abacavir, such as APO-ABACAVIR, KIVEXA®, TRIUMEQ® or ZIAGEN again, within hours you may experience a life-threatening lowering of your blood pressure or death.

Carry this card with you at all times.

You should return all of your unused APO-ABACAVIR to your healthcare professional for proper disposal.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02396769

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Apo-Abacavir

Rx or OTC
Prescription (Rx)?
DIN 02396769
Schedule(s) PRESCRIPTION
Active ingredient(s) Abacavir (abacavir sulfate) 300 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J05 Antivirals for systemic use
      1. J05A Direct acting antivirals
        1. J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
          1. J05AF06 Abacavir
Company APOTEX INC
Current status Marketed
Current status date March 15, 2016

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.